Latest Blogs

Sep 16, 2021
Dr. Atlal Abusanad discusses how biases in valuing capability and potential in female oncologists has led to their underrepresentation in prominent roles. 
Sep 09, 2021
"I think of my fellowship studies as a series of layers—every time I do well at one layer, I am ready to move to the next one," said Dr. Tarek Haykal.
Sep 01, 2021
There has never been a more exciting time to be involved in cancer research, with so much knowledge to support our explorations and so many pressing questions still to answer.
Aug 25, 2021
"COVID-19 has taught us how we can both live in the present and focus on the future; how we can make the most out of our time, regardless of our physical condition," said Dr. Hilde M. Buiting.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine at Brown University, director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Jul 31, 2018
A precision therapy was indicated and available for my patient, but we lost the window of opportunity to administer it safely.
Jun 19, 2018
This was a patient who needed to do cancer her way, and making it about me was not going to work.
Jun 07, 2018
FASCO is something earned through service to ASCO and to the field of oncology. One cannot apply or pay a fee to receive it.
May 22, 2018
Sometimes cross-coverage means having hard conversations with patients who aren't ours, but who still deserve our expertise and our honesty.
Apr 24, 2018
For those not in our field, cancer is still seen as a devastating disease starting at the point of diagnosis. As oncology professionals, it’s important that we do not accept death from cancer as inevitable, or even as imminent.
Apr 17, 2018
Clinical trials are the pathway to better treatments, better outcomes, and a future without cancer. We, as investigators, need to believe in them, and be willing to offer them to all patients who are eligible. 

Pages